Ładuje się......
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
BACKGROUND: Cetuximab, an anti-EGFR monoclonal antibody, is used to treat several cancers. However, many patients who initially respond to cetuximab acquire resistance. To examine mechanisms of acquired resistance, we developed a series of cetuximab-resistant (Ctx(R)) clones derived from the cetuxim...
Zapisane w:
| Wydane w: | Mol Cancer |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283113/ https://ncbi.nlm.nih.gov/pubmed/25344208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-242 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|